Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Nat Commun ; 12(1): 3560, 2021 06 11.
Article in English | MEDLINE | ID: covidwho-1265953

ABSTRACT

Non-pharmaceutical interventions (NPIs) remain the only widely available tool for controlling the ongoing SARS-CoV-2 pandemic. We estimated weekly values of the effective basic reproductive number (Reff) using a mechanistic metapopulation model and associated these with county-level characteristics and NPIs in the United States (US). Interventions that included school and leisure activities closure and nursing home visiting bans were all associated with a median Reff below 1 when combined with either stay at home orders (median Reff 0.97, 95% confidence interval (CI) 0.58-1.39) or face masks (median Reff 0.97, 95% CI 0.58-1.39). While direct causal effects of interventions remain unclear, our results suggest that relaxation of some NPIs will need to be counterbalanced by continuation and/or implementation of others.


Subject(s)
COVID-19/prevention & control , COVID-19/transmission , Health Policy , Infection Control/methods , Basic Reproduction Number , COVID-19/epidemiology , Disease Transmission, Infectious/prevention & control , Humans , Leisure Activities , Masks , Natural History , Pandemics , Quarantine , SARS-CoV-2/isolation & purification , Schools , United States/epidemiology
2.
Nat Commun ; 11(1): 4704, 2020 09 17.
Article in English | MEDLINE | ID: covidwho-779998

ABSTRACT

Many public health responses and modeled scenarios for COVID-19 outbreaks caused by SARS-CoV-2 assume that infection results in an immune response that protects individuals from future infections or illness for some amount of time. The presence or absence of protective immunity due to infection or vaccination (when available) will affect future transmission and illness severity. Here, we review the scientific literature on antibody immunity to coronaviruses, including SARS-CoV-2 as well as the related SARS-CoV, MERS-CoV and endemic human coronaviruses (HCoVs). We reviewed 2,452 abstracts and identified 491 manuscripts relevant to 5 areas of focus: 1) antibody kinetics, 2) correlates of protection, 3) immunopathogenesis, 4) antigenic diversity and cross-reactivity, and 5) population seroprevalence. While further studies of SARS-CoV-2 are necessary to determine immune responses, evidence from other coronaviruses can provide clues and guide future research.


Subject(s)
Antibodies, Viral/immunology , Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , COVID-19 , Coronavirus Infections/therapy , Cross Reactions , Databases, Factual , Humans , Immunization, Passive , Immunoglobulin Isotypes/immunology , Middle East Respiratory Syndrome Coronavirus/immunology , Pandemics , Pneumonia, Viral/therapy , SARS-CoV-2 , Seroepidemiologic Studies
SELECTION OF CITATIONS
SEARCH DETAIL